Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sudarshan Hebbar

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Contributions to Nephrology|June 2, 2012
Prospective safety study of bardoxolone methyl in patients with type 2 diabetes mellitus, end-stage renal disease and peritoneal dialysisDavid G Warnock, Sudarshan Hebbar, Joanne Bargman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 29, 2003
Factors associated with medication-related problems in ambulatory hemodialysis patientsHarold J Manley, Marcy L McClaran, Debra K Overbay, et al.
Gynecologic Oncology|October 16, 2012
The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic massKaren K L Chan, Chi-An Chen, Joo-Hyun Nam, et al.
Eclinicalmedicine|April 6, 2026
Zegocractin for acute pancreatitis with systemic inflammatory response syndrome: a randomized, controlled, dose-ranging, phase 2b trialRobert Sutton, Pramod K Garg, Joseph Miller, et al.
Journal of Gynecologic Oncology|October 14, 2014
Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findingsSarikapan Wilailak, Karen K L Chan, Chi An Chen, et al.
BMC Emergency Medicine|January 29, 2021
Derivation and validation of the ED-SAS score for very early prediction of mortality and morbidity with acute pancreatitis: a retrospective observational studyJoseph Miller, Yiyang Wu, Rawan Safa, et al.
JCI Insight|May 25, 2023
Orai1 calcium channel inhibition prevents progression of chronic pancreatitisViktória Szabó, Noémi Csákány-Papp, Marietta Görög, et al.
JCI Insight|November 10, 2025
Combination of Orai1 inhibitor CM5480 with specific therapy mitigates pulmonary hypertension and its cardiac dysfunctionAnaïs Saint-Martin Willer, Grégoire Ruffenach, Bastien Masson, et al.
Journal of the American College of Cardiology|January 14, 2012
Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort studyThomas L Nickolas, Kai M Schmidt-Ott, Pietro Canetta, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Contributions to Nephrology|June 2, 2012
Prospective safety study of bardoxolone methyl in patients with type 2 diabetes mellitus, end-stage renal disease and peritoneal dialysisDavid G Warnock, Sudarshan Hebbar, Joanne Bargman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 29, 2003
Factors associated with medication-related problems in ambulatory hemodialysis patientsHarold J Manley, Marcy L McClaran, Debra K Overbay, et al.
Gynecologic Oncology|October 16, 2012
The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic massKaren K L Chan, Chi-An Chen, Joo-Hyun Nam, et al.
Eclinicalmedicine|April 6, 2026
Zegocractin for acute pancreatitis with systemic inflammatory response syndrome: a randomized, controlled, dose-ranging, phase 2b trialRobert Sutton, Pramod K Garg, Joseph Miller, et al.
Journal of Gynecologic Oncology|October 14, 2014
Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findingsSarikapan Wilailak, Karen K L Chan, Chi An Chen, et al.
BMC Emergency Medicine|January 29, 2021
Derivation and validation of the ED-SAS score for very early prediction of mortality and morbidity with acute pancreatitis: a retrospective observational studyJoseph Miller, Yiyang Wu, Rawan Safa, et al.
JCI Insight|May 25, 2023
Orai1 calcium channel inhibition prevents progression of chronic pancreatitisViktória Szabó, Noémi Csákány-Papp, Marietta Görög, et al.
JCI Insight|November 10, 2025
Combination of Orai1 inhibitor CM5480 with specific therapy mitigates pulmonary hypertension and its cardiac dysfunctionAnaïs Saint-Martin Willer, Grégoire Ruffenach, Bastien Masson, et al.
Journal of the American College of Cardiology|January 14, 2012
Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort studyThomas L Nickolas, Kai M Schmidt-Ott, Pietro Canetta, et al.
Pageof 2